“hodgkins-disease” Archives

Entry Author Date Location
Cell Therapeutics Shares Boom, Vulcan’s Breast Cancer Bombshell, Microsoft Buys Rosetta Assets, & More Seattle-Area Life Sciences News 06/04/09 Seattle
ASCO Weekend Recap: OncoGenex, Seattle Genetics, Vulcan-Backed BiPar Show Off Cancer Drug Results 06/01/09 Seattle
Seattle Genetics “Empowered Antibody” Wipes Out Hodgkin’s Tumors in Early Study 06/01/09 Seattle
Why Should the Public Care About Biotech? Why is the Answer Always Jobs? 04/24/09 Seattle
Genzyme Enters Seattle Hub, Oncothyreon Bets on Cancer Drugs, Pathway Nabs $40M, & More Seattle-Area Life Sciences News 04/02/09 Seattle
Seattle Genetics Gets Fast Track 03/30/09 Seattle
Souped-Up Herceptin Aims to Validate ImmunoGen’s Long-Sought Dream Cancer Drug 03/06/09 Boston
UW’s Gardasil Windfall, Cell Therapeutics Unloads Zevalin, Trubion Cuts Jobs, & More Seattle-Area Life Sciences News 02/26/09 Seattle
Seattle Genetics Starts Pivotal Trial 02/19/09 Seattle
Seattle Genetics Defies Gravity With Biotech’s First Underwritten Stock Sale in Six Months 02/05/09 Seattle
Seattle Genetics Raises $55M 01/28/09 Seattle
Seattle Genetics Gets Orphan Drug Status 01/26/09 Seattle
Dendreon Expects Results in April, Seattle Genetics Plans Hodgkin’s Trial, ImaRx Moves to Town & More Seattle-Area Life Sciences News 01/22/09 Seattle
Seattle Genetics Unveils Pivotal Trial Plan for “Empowered Antibody” 01/21/09 Seattle
Seattle Genetics Drug Fights Hodgkin’s, Frazier Sounds Off on Biotech Ventures, SBRI Pushes Malaria Vaccine, & More Seattle-Area Life Sciences News 12/11/08 Seattle
Seattle Genetics “Empowered Antibody” Shines at Blood Disease Meeting 12/06/08 Seattle
Seattle Genetics Hires Waller To Lead Regulatory Affairs, as SGN-35 Heads to Pivotal Trial 09/30/08 Seattle
Seattle Genetics’ Medical Point Man, Tom Reynolds, Aims to Capitalize on Hodgkin’s Drug 09/08/08 Seattle
Page 2 of 2 « previous page